跳至主要内容
临床试验/NCT04212637
NCT04212637Unknown不适用

Study of Eye Movements (EYE) as Early Markers of Brain Dysfunction (BRAIN) in Parkinson's Disease (PARK)

University Hospital, Grenoble2 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2021年1月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
80
试验地点
2
主要终点
MRI images

研究概览

简要总结

Identify the neural bases of eye movements during visual tasks and their dysfunction at early stages of Parkinson disease (de novo).

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Visual acuity normal or corrected to normal
  • Affiliation to a social security scheme (copy of the vital card in support)
  • Signed informed consent
  • Medical examination according to the participation in the MRI examination
  • MMSE score> 23/30
  • For Parkinson patient:
  • Diagnosis of Parkinson's disease
  • Presence of asymmetric bradykinesia and rest tremor and / or stiffness
  • Hoehn & Yahr Stadium I-II / V

排除标准

  • Unprotected Majors unable to express their consent
  • Protected Major (Persons mentioned in Articles L1121-5,6 and 8 of the public health code)
  • Significant hearing or motor impairment
  • Past or present neuropsychiatric pathology (except benign epilepsy)
  • Taking narcotics and / or drugs for neurocognitive purposes
  • Existence of a severe condition in general (cardiac, respiratory, hematological, renal, hepatic, cancerous)
  • Any other neurodegenerative pathology or treatment that may affect the oculomotor control
  • For Parkinson patient:
  • Treatment for Parkinson's disease (except the inhibitors of monoaminoxidase B or MAO-B, such as selegiline and rasagiline).

结局指标

主要结局

MRI images

时间窗: 1 hour

Functional and anatomical brain volumes

次要结局

  • Eye latency(1 hour)
  • eye amplitude(1 hour)

研究者

发起方
University Hospital, Grenoble
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验